» Articles » PMID: 8262860

Mechanisms of Quinolone Resistance in Clinical Isolates: Accumulation of Sparfloxacin and of Fluoroquinolones of Various Hydrophobicity, and Analysis of Membrane Composition

Overview
Date 1993 Sep 1
PMID 8262860
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The accumulation of sparfloxacin and three other fluoroquinolones of decreasing hydrophobicity, pefloxacin, ofloxacin, and ciprofloxacin, into randomly chosen fluoroquinolone-sensitive and -resistant clinical isolates of bacteria (four Enterobacteriaceae, one Pseudomonas aeruginosa and one Staphylococcus aureus) was measured. There was good correlation between the concentration of drug that inhibited early DNA synthesis in whole cells and the MIC values of the same drug regardless of organism sensitivity or the quinolone. A decrease in permeability in resistant strains compared with sensitive, due to a modification of outer membrane proteins was often involved in resistance. But, in all cases other mutations may also be involved explaining the relatively high level of resistance of the strains. In two resistant strains the DNA gyrase was purified and found to be resistant to inhibition by quinolones. The use of quinolones of differing hydrophobicity emphasized the importance of this property in the uptake of quinolones by bacterial cells, and provided evidence that sparfloxacin used both porin and the self-promoted uptake pathway for it's uptake.

Citing Articles

Donnan Potential across the Outer Membrane of Gram-Negative Bacteria and Its Effect on the Permeability of Antibiotics.

Alegun O, Pandeya A, Cui J, Ojo I, Wei Y Antibiotics (Basel). 2021; 10(6).

PMID: 34208097 PMC: 8230823. DOI: 10.3390/antibiotics10060701.


Fluorescence quenching as a tool to investigate quinolone antibiotic interactions with bacterial protein OmpF.

Neves P, Sousa I, Winterhalter M, Gameiro P J Membr Biol. 2009; 227(3):133-40.

PMID: 19148694 DOI: 10.1007/s00232-008-9152-2.


Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.

Yu X, Susa M, Knabbe C, Schmid R, Bachmann T J Clin Microbiol. 2004; 42(9):4083-91.

PMID: 15364994 PMC: 516282. DOI: 10.1128/JCM.42.9.4083-4091.2004.


Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Raherison S, Gonzalez P, Renaudin H, Charron A, Bebear C, Bebear C Antimicrob Agents Chemother. 2002; 46(3):672-9.

PMID: 11850247 PMC: 127495. DOI: 10.1128/AAC.46.3.672-679.2002.


Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae.

Chevalier J, Mallea M, Pages J Biochem J. 2000; 348 Pt 1:223-7.

PMID: 10794735 PMC: 1221057.